Target intelligence / Profile preview

Ribosomal protein S26 pseudogene 30 (RPS26P30)

Target
RPS26P30
Molecular classification
Other (pseudogene), Related to Ribosomal protein family (specifically S26)
01

Overview

Ribosomal protein S26 pseudogene 30 (RPS26P30) is a non-functional genomic sequence classified as a *pseudogene* derived from the ribosomal protein S26 (RPS26) gene[2][7][8]. Pseudogenes arise through duplication or retrotransposition; they are typically not transcribed into functional proteins and have no active biological function. While the parental RPS26 gene encodes a component of the small subunit (40S) of the ribosome and plays a role in protein synthesis, the RPS26P30 pseudogene does not contribute to ribosomal structure or function[3][7][8]. It is not a viable pharmacological or therapeutic target.

Other names
RPS26P30RPS26_7_791RPS26P30 (no common alternative names found beyond the synonyms listed)
02

Mechanism of action

None

03

Biological functions

None for the pseudogene itself[7][8]The parent gene (RPS26) is involved in protein synthesis as part of the ribosome, but this pseudogene does *not* encode a functional protein[2][7][8]
04

Disease associations

None for the pseudogene itself[7][8]The functional RPS26 gene has pathogenic variants linked to Diamond-Blackfan anemia, but pseudogenes generally do not contribute to disease[3][4][7][8]
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on Ribosomal protein S26 pseudogene 30 (RPS26P30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S26 pseudogene 30 (RPS26P30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call